Skip to Main Content

Julie R. Park, MD

Member, St. Jude Faculty

Chair, Department of Oncology

Associate Director Comprehensive Cancer Center, Translational Research

Endowed Chair in Pediatric Oncology

On this page:

Contact Information

Julie R. Park, MD

Oncology

MS 260, Room C6008

St. Jude Children's Research Hospital

262 Danny Thomas Place

MemphisTN 38105-3678

Education

Fellowship (Leukemia Society of America) - Fred Hutchinson Cancer Research Center, Seattle, Washington Fellowship (Pediatric Hematology/Oncology) – University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington Residency (Pediatrics) – University of Washington, Seattle, Washington MD – University of Vermont, College of Medicine, Burlington, Vermont BA – University of Vermont, College of Arts and Science, Burlington, Vermont

Honors & Awards

  • 1995  William Guy Forbeck Research Foundation Scholar Award
  • 2003  University of Vermont, Recent Alumni Award
  • 2009  Bushnell Towne Wilkerson Endowed Chair in Pediatric Neuroblastoma
  • 2010  American Pediatric Society
  • 2018  American Society of Pediatric Hematology Oncology Frank Oski Award
  • 2023  Distinguished Academic Achievement Award, The Lerner College of Medicine
  • 2002-to date  American Society of Clinical Oncology
  • 2006-to date  American Society of Pediatric Hematology Oncology
  • 2007-2011  COG Neuroblastoma Discipline Vice-Chair
  • 2009-to date  UpToDate – Section Editor, Pediatric Oncology
  • 2011-2019  COG Neuroblastoma Discipline Chair
  • 2019to date  Scientific chair of the New Approaches to Neuroblastoma Therapy consortium
  • 2023  President, Advances in Neuroblastoma Research

Research Interests

  • Translational research to improve survival of children with cancer
  • Development of cellular immunotherapy trials for pediatric cancer
  • Immuno-oncology
  • Novel cellular immunotherapy for refractory and recurrent pediatric malignancies
  • Neuroblastoma
  • New Approaches to Neuroblastoma Therapy
  • Novel drug development for high-risk neuroblastoma

Dr. Park Featured Stories